Tarakji B, Kujan O. An immunohistochemical study of androgen
receptor in carcinoma arising in pleomorphic salivary
adenoma. Med Oral Patol Oral
Cir Bucal. 2011 May 1;16
(3):e330-4.
doi:10.4317/medoral.16.e330
1. Olejniczak I, Kozłowski Z, Dabrowska K, Lukomski M. [Tumors
of the parotid gland--management and results of surgical treatment]. Otolaryngol Pol. 2008;62:446-50.
doi:10.1016/S0030-6657(08)70289-0
2. Do Prado RF, Consolaro A, Taveira
LA. Expression of betacatenin in
carcinoma in pleomorphic adenoma, pleomorphic
adenoma and normal salivary gland: an immunohistochemical
study. Med Oral Patol Oral Cir Bucal. 2006;11:E247-51.
3. Early Breast Cancer Trialists’ Collaborative Group
(EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer
on recurrence and 15-year survival: an overview of the randomised
trials. Lancet. 2005;365:1687-717.
doi:10.1016/S0140-6736(05)66544-0
4. Berthelet E, Pickles T, Lee KW, Liu M, Truong PT; Prostate Cancer Outcomes
Initiative. Long-term androgen deprivation therapy improves survival in
prostate cancer patients presenting with prostate-specific antigen levels >
20 ng/mL. Int J Radiat Oncol
Biol Phys. 2005;63:781-7.
doi:10.1016/j.ijrobp.2005.02.034
PMid:16199312
5. Ma CX, Sanchez CG, Ellis MJ. Predicting endocrine therapy
responsiveness in breast cancer. Oncology (Williston
Park). 2009;23:133-42.
PMid:19323294
6. Pertschuk LP, Eisenberg KB, Carter AC, Feldman JG.
Immunohistologic localization of estrogen receptors in breast cancer with
monoclonal antibodies. Correlation with biochemistry
and clinical endocrine response. Cancer. 1985;55:1513-8.
doi:10.1002/1097-0142(19850401)55:7<1513::AID-CNCR2820550717>3.0.CO;2-4
7. Singh Y, Sayami P, Sayami
G, Nakagawa H, Koreeda T, Hatano
T, et al. Nepalese breast cancer in relation to reproductive factors:
comparison between Nepalese and Japanese cases. Anticancer Res. 2002;22:319-23.
PMid:12017310
8. Dimery IW, Jones LA, Verjan
RP, Raymond AK, Goepfert H, Hong WK. Estrogen
receptors in normal salivary gland and salivary gland carcinoma. Arch Otolaryngol Head Neck Surg. 1987;113:1082-5.
PMid:3620130
9. Driscoll MS, Grant-Kels JM.
Estrogen receptor expression in cutaneous
melanoma. Arch Dermatol.
2009;145:73-5.
doi:10.1001/archdermatol.2008.539
PMid:19153347
10. Ripoll C, Ropero AB, Alonso-Magdalena
P, Quesada I, Fuentes E, Nadal A. Rapid regulation of
pancreatic alpha- and beta- cell signalling systems
by estrogens. Infect Disord Drug Targets. 2008;8:61-4.
PMid:18473909
11. Birsak
CA, Janssen PJ, van Vroonhoven CC, Peterse JL, van der Kwast TH. Sex steroid receptor
expression in ‘carcinoid’ tumours
of the breast. Breast Cancer Res Treat. 1996;40:243-9.
doi:10.1007/BF01806812
PMid:8883966
12. Mai KT, Teo I, Belanger EC, Robertson SJ, Marginean EC, Islam S. Progesterone receptor reactivity in
renal oncocytoma and chromophobe
renal cell carcinoma. Histopathology. 2008;52:277-82.
doi:10.1111/j.1365-2559.2007.02931.x
PMid:18081814
13. Nagao K, Matsuzaki O, Saiga
H, Sugano I, Shigematsu H, Kaneko T, et al. Histopathologic studies on carcinoma in pleomorphic
adenoma of the parotid gland. Cancer. 1981;48:113-21.
doi:10.1002/1097-0142(19810701)48:1<113::AID-CNCR2820480122>3.0.CO;2-F
14. Azuma M, Kasai Y, Tamatani T,
Sato M. Involvement of p53 mutation in the development of human salivary gland pleomorphic adenomas. Cancer Lett. 199;65:61-71.
15. Yamamoto Y, Kishimoto Y, Virmani
AK, Smith A, Vuitch F, Albores-Saavedra
J, et al. Mutations associated with carcinomas arising from pleomorphic
adenomas of the salivary glands. Hum Pathol. 1996;27:782-6.
doi:10.1016/S0046-8177(96)90449-9
16. Yamamoto Y, Kishimoto Y, Wistuba
II, Virmani AK, Vuitch F, Gazdar AF, et al. DNA analysis at p53 locus in carcinomas
arising from pleomorphic adenomas of salivary glands:
comparison of molecular study and p53 immunostaining.
Pathol Int. 1998;48:265-72.
doi:10.1111/j.1440-1827.1998.tb03904.x
PMid:9648154
17. Lewy-Trenda I. Estrogen and progesterone receptors in neoplastic
and non-neoplastic thyroid lesions. Pol J Pathol. 2002;53:67-72.
PMid:12140869
18. Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R. Steroid hormone receptor expression in renal cell
carcinoma: an immunohistochemical analysis of 182
tumors. J Urol. 2004;171:611-4.
doi:10.1097/01.ju.0000108040.14303.c2
PMid:14713771
19. Chaudhuri PK, Walker MJ, Briele
HA, Beattie CW, Gupta TK. Incidence of estrogen receptor in benign nevi and
human malignant melanoma. JAMA. 1980;244:791-3.
doi:10.1001/jama.244.8.791
PMid:7392187
20. Gelmann EP. Molecular biology
of the androgen receptor. J Clin
Oncol. 2002;20:3001-15.
doi:10.1200/JCO.2002.10.018
PMid:12089231
21. Roy AK, Tyagi RK, Song CS, Lavrovsky
Y, Ahn SC, Oh TS, et al. Androgen receptor:
structural domains and functional dynamics after ligand-receptor
interaction. Ann N Y Acad Sci. 2001;949:44-57.
doi:10.1111/j.1749-6632.2001.tb04001.x
22. Fan CY, Wang J, Barnes EL.
Expression of androgen receptor and prostatic specific markers in salivary duct
carcinoma: an immunohistochemical analysis of 13
cases and review of the literature. Am J Surg Pathol. 2000;24:579-86.
doi:10.1097/00000478-200004000-00014
PMid:10757407
23. Fan CY, Melhem MF, Hosal
AS, Grandis JR, Barnes EL. Expression of androgen
receptor, epidermal growth factor receptor, and transforming growth factor
alpha in salivary duct carcinoma. Arch Otolaryngol
Head Neck Surg. 2001;127:1075-9.
PMid:11556855
24. Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone
receptors in salivary gland tumors. Frequent
expression of androgen receptor in a subset of malignant salivary gland tumors.
Am J Clin Pathol.
2003;119:801-6.
doi:10.1309/RVTP1G0Q727WJUQD
PMid:12817426
25. Kapadia SB, Barnes L. Expression of androgen receptor, gross cystic
disease fluid protein, and CD44 in salivary duct carcinoma. Mod Pathol. 1998;11:1033-8.
PMid:9831198
26. Moriki T, Ueta S,
Takahashi T, Mitani M, Ichien
M. Salivary duct carcinoma: cytologic characteristics
and application of androgen receptor immunostaining
for diagnosis. Cancer. 2001;93:344-50.
doi:10.1002/cncr.9050
PMid:11668470
27. Locati LD, Quattrone P,
Bossi P, Marchianò AV, Cantù G, Licitra L. A complete remission with androgen-deprivation therapy in a
recurrent androgen receptor-expressing adenocarcinoma
of the parotid gland. Ann Oncol. 2003;14:1327-8.
doi:10.1093/annonc/mdg331
PMid:12881399
28. Tarakji B, Nassani MZ. Immunohistochemical expression of p21 in normal tissues of salivary gland, pleomorphic adenoma and carcinoma ex pleomorphic
adenoma-(undifferentiated and adenocarcinoma types).
Med Oral Patol Oral Cir
Bucal. 2010;15:e697-703.
doi:10.4317/medoral.15.e697
29. Tarakji
B, Nassani MZ, Sloan P. Immunohistochemical
expression of estrogens and progesterone receptors in carcinoma ex pleomorphic adenoma-undifferentiated and adenocarcinoma types. Med Oral Patol Oral Cir
Bucal. 2010;15:e432-6.
doi:10.4317/medoral.15.e432